The News
M.D.: Drugmaker threatened suit as Avandia issues raised
By Matthew Perrone The Associated Press
Article Last Updated: 06/07/2007 01:44:32 AM MDT
Washington - The controversy surrounding GlaxoSmithKline's diabetes drug Avandia grew Wednesday as a medical expert told Congress that executives threatened to sue when he first raised questions in 1999 about the treatment's safety. That testimony, coupled with a recent medical journal's analysis highlighting the heart attack risks associated with Avandia, prompted some Democratic lawmakers to rebuke the Food and Drug Administration for failing to protect consumers.

The Research
Read the research behind this story in the New England Journal of Medicine.